Showing results (71-80 of 401) with videos related to
Sort By:
Pageof 41
Genes & Development|August 15, 2015
Neurofibromatosis-1 regulation of neural stem cell proliferation and multilineage differentiation operates through distinct RAS effector pathwaysYi-Hsien Chen, Scott M Gianino, David H GutmannCancer Epidemiology|March 29, 2016
Peri-gestational risk factors for pediatric brain tumors in Neurofibromatosis Type 1Kimberly J Johnson, Nancy L Zoellner, David H GutmannJournal of Child Neurology|September 2, 2016
Macrocephaly Is Not a Predictor of Optic Pathway Glioma Development or Treatment in Neurofibromatosis Type 1Stephanie M Morris, Courtney L Monroe, David H GutmannJournal of Attention Disorders|February 23, 2012
A neuropsychological perspective on attention problems in neurofibromatosis type 1Alexandra K Templer, Jeffrey B Titus, David H GutmannThe Journal of Clinical Investigation|April 6, 2006
Harnessing preclinical mouse models to inform human clinical cancer trialsDavid H Gutmann, Kim Hunter-Schaedle, Kevin M ShannonCancer Research|January 7, 2006
Mouse Models of Human Cancers Consortium Workshop on Nervous System TumorsDavid H Gutmann, Elizabeth A Maher, Terry Van DykeCancer Research|January 25, 2005
Glioma formation in neurofibromatosis 1 reflects preferential activation of K-RAS in astrocytesBiplab Dasgupta, Wen Li, Arie Perry, et al.Cancer Cell|July 14, 2012
Innate neural stem cell heterogeneity determines the patterning of glioma formation in childrenDa Yong Lee, Scott M Gianino, David H GutmannEpilepsia|October 13, 2017
Postnatal reduction of tuberous sclerosis complex 1 expression in astrocytes and neurons causes seizures in an age-dependent mannerJia Zou, Bo Zhang, David H Gutmann, et al.Journal of Cell Science|October 3, 2002
Protein 4.1 tumor suppressors: getting a FERM grip on growth regulationChun-Xiao Sun, Victoria A Robb, David H GutmannPageof 41